SLU-PP-332 5mg

Description

SLU-PP-332 5mg is an advanced research dose — well beyond the micro-dosing range and into the territory where ERR agonism is producing maximal transcriptional engagement. At 5mg, this compound is operating as a potent metabolic modifier: mitochondrial biogenesis is driven aggressively, fast-twitch to slow-twitch fibre transition is substantially accelerated, and the systemic metabolic shifts (fat oxidation, glucose management, cardiovascular adaptation) are pronounced. Animal research at equivalent dose ranges demonstrates dramatic endurance enhancement and body composition improvements, with skeletal muscle taking on the phenotypic characteristics of elite endurance athletes at the gene expression level. At this dose, the compound should be stacked with carnitine, CoQ10, and NAD+ precursors to support the metabolic infrastructure being driven by ERR activation. This is a performance-science frontier dose. Verified at 99%+ purity by Puralytix. At 5mg, systematic health monitoring (metabolic panels, liver function, cardiovascular assessment) is advisable given the limited long-term human pharmacokinetic data at this dose level. A comprehensive training log tracking VO2max, body composition, and performance metrics helps document the real-world adaptation rate.